
Occam recently recruited Lisa Deschamps to AviadoBio. She takes the helm of this neuro gene therapy company based on the scientific research of Chris Shaw of King’s College London after having had a distinguished career at Novartis in a variety of senior executive management positions in neuroscience and gene therapy. In addition to bringing deep content knowledge to Aviado, Lisa has also provided leadership for the company’s recently successful $80 million financing, bringing in new investors including NEA.
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.